MC1371A1 - Preparations pharmaceutiques - Google Patents

Preparations pharmaceutiques

Info

Publication number
MC1371A1
MC1371A1 MC811498A MC1498A MC1371A1 MC 1371 A1 MC1371 A1 MC 1371A1 MC 811498 A MC811498 A MC 811498A MC 1498 A MC1498 A MC 1498A MC 1371 A1 MC1371 A1 MC 1371A1
Authority
MC
Monaco
Prior art keywords
glycerin
ether
alkyl ether
lower alkyl
process according
Prior art date
Application number
MC811498A
Other languages
English (en)
French (fr)
Inventor
W Boguth
G Hirth
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1371A1 publication Critical patent/MC1371A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MC811498A 1980-02-07 1981-02-04 Preparations pharmaceutiques MC1371A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH98380 1980-02-07

Publications (1)

Publication Number Publication Date
MC1371A1 true MC1371A1 (fr) 1982-01-19

Family

ID=4199742

Family Applications (1)

Application Number Title Priority Date Filing Date
MC811498A MC1371A1 (fr) 1980-02-07 1981-02-04 Preparations pharmaceutiques

Country Status (17)

Country Link
US (3) US4339447A (enExample)
EP (1) EP0035132B1 (enExample)
JP (1) JPS56125316A (enExample)
AR (1) AR226334A1 (enExample)
AU (1) AU6676481A (enExample)
CA (1) CA1158161A (enExample)
DE (1) DE3170972D1 (enExample)
DK (1) DK47681A (enExample)
FI (1) FI803846L (enExample)
GR (1) GR70308B (enExample)
IE (1) IE810231L (enExample)
IL (1) IL62041A0 (enExample)
MC (1) MC1371A1 (enExample)
NO (1) NO810422L (enExample)
NZ (1) NZ196153A (enExample)
PH (1) PH17121A (enExample)
ZA (1) ZA81650B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3343530A1 (de) * 1983-12-01 1985-06-13 Max Planck Gesellschaft Arzneimittel mit verbesserter penetration der gewebsmembran
DE3583698D1 (de) * 1984-04-23 1991-09-12 Kao Corp Perkutaner absorptions-beschleuniger und diesen enthaltendes praeparat.
JPS60224638A (ja) * 1984-04-23 1985-11-09 Kao Corp 経皮吸収促進剤およびこれを含有する外用剤
GB8432542D0 (en) * 1984-12-21 1985-02-06 Micropore International Ltd Power control arrangement
US5462740A (en) * 1993-09-17 1995-10-31 Athena Neurosciences, Inc. Rectally-administered, epileptic-seizure-inhibiting composition
US20110038899A1 (en) * 2008-03-28 2011-02-17 Garry Thomas Gwozdz Pharmaceutical Solutions and Method for Solublilizing Therapeutic Agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1752305A (en) * 1925-04-21 1930-04-01 Winthrop Chem Co Solution of medicament and process of preparing same
DE2038107A1 (de) * 1970-07-31 1972-02-10 Henkel & Cie Gmbh Fluessige,gegebenenfalls als Wasch- oder Reinigungsmittel brauchbare stabilisierte Enzympraeparate
DE2058820A1 (de) 1970-11-30 1972-05-31 Siempelkamp Gmbh & Co Verfahren und Einrichtung zum Herstellen von Holzwerkstoffplatten
DE2252637C3 (de) * 1972-10-26 1979-07-19 Klinge Pharma Gmbh & Co, 8000 Muenchen Verwendung von 1,3-Glycerindiäthern
DE2708419C3 (de) 1977-02-26 1979-08-16 Basf Ag, 6700 Ludwigshafen Verwendung von 1,2-Butandiol-lmethyläther als Lösungsmittel für pharmazeutische Injektionslösungen

Also Published As

Publication number Publication date
AU6676481A (en) 1981-08-13
FI803846A7 (fi) 1981-08-08
IE810231L (en) 1981-08-07
JPS56125316A (en) 1981-10-01
AR226334A1 (es) 1982-06-30
DK47681A (da) 1981-08-08
US4393057A (en) 1983-07-12
GR70308B (enExample) 1982-09-08
EP0035132A3 (en) 1982-09-29
FI803846L (fi) 1981-08-08
EP0035132A2 (de) 1981-09-09
US4339447A (en) 1982-07-13
IL62041A0 (en) 1981-03-31
EP0035132B1 (de) 1985-06-19
PH17121A (en) 1984-06-01
CA1158161A (en) 1983-12-06
NZ196153A (en) 1983-07-29
US4393073A (en) 1983-07-12
NO810422L (no) 1981-08-10
ZA81650B (en) 1982-03-31
DE3170972D1 (en) 1985-07-25

Similar Documents

Publication Publication Date Title
EP0593656B3 (fr) Nouvelles compositions a base de derives de la classe des taxanes
EP0669131B1 (fr) Solutions aqueuses concentrées d'argatroban
EP0173729B1 (fr) Ppocede de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues
KR100401119B1 (ko) 택산계열유도체-기본약학조성물
EP0862423B1 (fr) Composition pharmaceutique pour administration par voie orale
FR2519864A1 (fr) Composition huileuse a base de medicaments antitumoraux
CH630260A5 (fr) Compositions antibiotiques a base d'une tetracycline.
FR2482456A1 (fr) Composition en gel, anti-inflammatoire et analgesique, a base de ketoprofene et/ou de flurbiprofene
JPH09504012A (ja) シクロスポリンA及びα−トコフェロールを含有する医薬組成物
LU83423A1 (fr) Pneumatique radial pour vehicules tout-terrain
FR2620336A1 (fr) Utilisation de monoesters solubles dans l'eau d'acides gras comme solubilisants de medicaments
RS20070461A (sr) Injektibilne kompozicije i postupak za njihovo dobijanje
KR0168436B1 (ko) 비스테로이드계 소염진통제를 함유하는 수중유형 유화 조성물
JP3519414B2 (ja) サイクロポリン含有軟質カプセル製剤
FR2584405A1 (fr) Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation
EP0493496A1 (en) Ibuprofen triturates and topical compositions containing same
MC1371A1 (fr) Preparations pharmaceutiques
FR2598320A1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
CA2119270A1 (fr) Sels de sparfloxacine et solutions les contenant
CA1275247C (fr) Procede de solubilisation, au moment de l'emploi, d'un principe actiflipophile dans une solution aqueuse, en vue de son administration par voie intraveineuse
MC1485A1 (fr) Procede de preparation de solutions aqueuses de sulfonamides potentialises
FI96742B (fi) Minoksidiilia sisältävä 1-faasigeelikoostumus ja menetelmä sen valmistamiseksi
CA2188599C (fr) Compositions pharmaceutiques a base de derives de la classe des taxanes
FR2544198A1 (fr) Compositions pharmaceutiques topiques a base d'acide meclophenamique
JPH07126159A (ja) 乳剤性軟膏剤

Legal Events

Date Code Title Description
YP Annual fee paid